Unknown

Dataset Information

Evidence for the role of corticotropin-releasing factor in major depressive disorder.


ABSTRACT: Major depressive disorder (MDD) is a devastating disease affecting over 300 million people worldwide, and costing an estimated 380 billion Euros in lost productivity and health care in the European Union alone. Although a wealth of research has been directed toward understanding and treating MDD, still no therapy has proved to be consistently and reliably effective in interrupting the symptoms of this disease. Recent clinical and preclinical studies, using genetic screening and transgenic rodents, respectively, suggest a major role of the CRF1 gene, and the central expression of CRF1 receptor protein in determining an individual's risk of developing MDD. This gene is widely expressed in brain tissue, and regulates an organism's immediate and long-term responses to social and environmental

SUBMITTER: Waters RP 

PROVIDER: S-EPMC4828243 | biostudies-literature | 2015 Nov

REPOSITORIES: biostudies-literature